Sanofi has sent letters to 340B covered entities that have complained to HRSA about the drug manufacturer's denials of 340B pricing on drugs shipped to contract pharmacies.

Sanofi Reaches Out to 340B Entities that Complained to HRSA About its Contract Pharmacy Restrictions

Drug manufacturer Sanofi has sent letters to 340B covered entities that have complained to federal authorities about its denials of 340B pricing on drugs shipped to contract pharmacies, covered entity representatives say.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content